Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
New prophylactic and therapeutic avenues to fight against rabies

New prophylactic and therapeutic avenues to fight against rabies

New treatment effective at reversing the manifestations of thyroid eye disease

New treatment effective at reversing the manifestations of thyroid eye disease

New treatment target for acute kidney injury prevention revealed

New treatment target for acute kidney injury prevention revealed

Hendra antibody trial shows promise in a world-first human clinical trial

Hendra antibody trial shows promise in a world-first human clinical trial

AMSBIO announces new Custom CAR-T development service

AMSBIO announces new Custom CAR-T development service

New treatment target could change the outlook of patients at risk of kidney injury

New treatment target could change the outlook of patients at risk of kidney injury

Clinical trial to test safety, effectiveness of mAb against malaria in healthy volunteers

Clinical trial to test safety, effectiveness of mAb against malaria in healthy volunteers

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

Genetically engineered mosquitoes halt Dengue spread

Genetically engineered mosquitoes halt Dengue spread

New antibody-drug conjugate shows promising activity in salivary gland tumors

New antibody-drug conjugate shows promising activity in salivary gland tumors

Bile acids help norovirus to infect cells of the small intestine

Bile acids help norovirus to infect cells of the small intestine

New dementia vaccine may proceed to clinical trials after successful testing

New dementia vaccine may proceed to clinical trials after successful testing

New antibody shows promise in active lupus

New antibody shows promise in active lupus

Study: Blocking IL1α protein decreases severity of inflammation in Crohn's disease

Study: Blocking IL1α protein decreases severity of inflammation in Crohn's disease

Immunotherapy: A promising new alternative to cancer therapies

Immunotherapy: A promising new alternative to cancer therapies

Combination therapy is safe and effective for older patients diagnosed with acute lymphoblastic leukemia

Combination therapy is safe and effective for older patients diagnosed with acute lymphoblastic leukemia

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Experimental therapies offer patients a greater chance of surviving Ebola virus disease

Experimental therapies offer patients a greater chance of surviving Ebola virus disease

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

Lonza launches new basal and feed medium to optimize protein production

Lonza launches new basal and feed medium to optimize protein production